Skin Cancer Oncology Radiation Evidence Registry (SCORER)

GenesisCare

Status: Terminated

Conditions: Non-melanoma Skin Cancer

Treatments: Behavioral: There is no medical intervention for the purposes of this Registry.

Study type: Observational

Funder types: Other

Identifiers

NCT04681456

GCUSA-2020-03

Details and patient eligibility

About

To collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer. A target of 400 VMAT-treated sites is set which is estimated to be identified in approximately 350 participants. Participants referred for radiotherapy for the management of non-melanoma skin cancer.

Full description

The Registry will collect information on key clinical indications and patient reported outcomes to assess the safety and efficacy of VMAT radiotherapy. Data that will be collected includes baseline data of demographic, relevant medical history, photographs, treatment schedule, and treatment outcomes. Data may be collected retrospectively in regard to previous relevant medical history, prior treatments and outcomes as well as prospectively, including treatment schedule and treatment outcomes of radiotherapy treatment.

The Registry aims to assess the safety and outcomes of treatment for up to 5 years. This Registry will be the first of its kind in the US and will provide a basis for a number of potential research publications. The Registry will also give insights into treatment delivery and potentially facilitate future improvements in patient care.

Enrollment: 350 patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Over 18 years of age
• Diagnosed with a treatable non-melanoma skin cancer by referring medical practitioner
• Eligible to be treated using widefield (>50cm2) VMAT radiotherapy as determined by RO
• Patient has provided written informed consent.

Exclusion criteria

♦ Patients who do not consent to their involvement in the Registry.